Varian Medical Systems (VAR) Stock Price, News & Analysis

Company Overview

Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through Oncology Systems and Proton Solutions segments. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, artificial intelligence based adaptive radiotherapy, and brachytherapy, as well as quality assurance equipment. Its products include linear accelerators, brachytherapy afterloaders, treatment accessories, and quality assurance software; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians' offices, medical oncology practices, radiotherapy centers, and cancer care clinics. The Proton Solutions segment designs, develops, manufactures, sells, and services products and systems for delivering proton therapy for the treatment of cancer. The company has a strategic agreement with McKesson Corp. to supply treatment delivery systems and planning, services, and radiotherapy information system solutions to its U.S. Oncology Network and Vantage Oncology affiliated sites of care; and a strategic partnership with Siemens AG to represent Siemens diagnostic imaging products to radiation oncology clinics in the United States and other select markets. Varian Medical Systems, Inc. was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. The company was founded in 1948 and is headquartered in Palo Alto, California.

Key Stats

• Today's Range: $177.07 to $177.07
• 50-Day Range: $176.53 to $177.29
• 52-Week Range: $103.67 to $177.38
• Volume: N/A
• Average Volume: 746,779 shs
• Market Capitalization: $16.26 billion
• P/E Ratio: 60.43
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Varian Medical Systems Stock Analysis - MarketRank™

Varian Medical Systems scored higher than 19% of companies evaluated by MarketBeat, and ranked 875th out of 932 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Varian Medical Systems.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: 13.08%

Earnings Growth

Earnings for Varian Medical Systems are expected to grow by 13.08% in the coming year, from $5.20 to $5.88 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Varian Medical Systems is 60.43, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 22.60.

Price to Earnings Ratio vs. Sector

The P/E ratio of Varian Medical Systems is 60.43, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 23.62.

Price to Book Value per Share Ratio

Varian Medical Systems has a P/B Ratio of 7.73. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for VAR.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Varian Medical Systems does not currently pay a dividend.

Dividend Growth

Varian Medical Systems does not have a long track record of dividend growth.

Sustainability and ESG

• Score: 4.4 / 5
• Environmental Score: -0.79

Short Interest

There is no current short interest data available for VAR.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Varian Medical Systems this week, compared to 0 articles on an average week.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Varian Medical Systems insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.78% of the stock of Varian Medical Systems is held by insiders.

Percentage Held by Institutions

86.96% of the stock of Varian Medical Systems is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

VAR Stock Analysis - Frequently Asked Questions

How were Varian Medical Systems' earnings last quarter?

Varian Medical Systems, Inc. (NYSE:VAR) released its quarterly earnings results on Monday, January, 25th. The medical equipment provider reported $1.14 EPS for the quarter, topping the consensus estimate of $1.10 by $0.04. The business's revenue for the quarter was down 6.1% compared to the same quarter last year.

Does Varian Medical Systems have any subsidiaries?

Varian Medical Systems subsidiaries include Boston Scientific, Endocare, CTSI, CTSI, Mobius Medical Systems, PerkinElmer's Medical Imaging Business, Candela's radiotherapy business, and others.

What other stocks do shareholders of Varian Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Varian Medical Systems investors own include NVIDIA (NVDA), Meta Platforms (META), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Pfizer (PFE), Vertex Pharmaceuticals (VRTX) and Exxon Mobil (XOM).

Company Calendar

• Last Earnings: 1/25/2021
• Today: 4/01/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Electromedical Equipment
• Sub-Industry: Health Care Equipment
• Current Symbol: NYSE:VAR
• CIK: 203527
• Web: www.varian.com
• Phone: 650-493-4000
• Fax: N/A
• Employees: 10,000
• Year Founded: 1948

Profitability

• EPS (Most Recent Fiscal Year): $3.91
• Trailing P/E Ratio: 60.43
• Forward P/E Ratio: 34.05
• P/E Growth: N/A
• Net Income: $269.20 million
• Net Margins: 8.50%
• Pretax Margin: N/A
• Return on Equity: 18.45%
• Return on Assets: 8.08%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.40
• Quick Ratio: 1.13

Sales & Book Value

• Annual Sales: $3.17 billion
• Price / Sales: 5.13
• Cash Flow: $5.07 per share
• Price / Cash Flow: 34.94
• Book Value: $22.92 per share
• Price / Book: 7.73

Miscellaneous

• Outstanding Shares: 91,839,000
• Free Float: N/A
• Market Cap: $16.26 billion
• Optionable: Optionable
• Beta: 1.06